Journal
IMMUNITY
Volume 51, Issue 6, Pages 1028-+Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2019.10.009
Keywords
-
Categories
Funding
- NIH [AI125741, DK108557]
- American Cancer Society (ACS) Research Scholar Grant
- A Healthier Wisconsin (AHW) Grant
- Cancer Research Institute Irvington Fellowship
- Elizabeth Elser Doolittle Postdoctoral Fellowship
- NIGMS [T32-GM080202]
Ask authors/readers for more resources
Although CD4(+) T cell help is crucial to sustain antiviral immunity, the mechanisms by which CD4(+) T cells regulate CD8(+) T cell differentiation during chronic infection remain elusive. Here, using single-cell RNA sequencing, we show that CD8(+) T cells responding to chronic infection were more heterogeneous than previously appreciated. Importantly, our findings uncovered the formation of a CX(3)CR1-expressing CD8(+) T cell subset that exhibited potent cytolytic function and was required for viral control. Notably, our data further demonstrate that formation of this cytotoxic subset was critically dependent on CD4(+) T cell help via interleukin-21 (IL-21) and that exploitation of this developmental pathway could be used therapeutically to enhance the killer function of CD8(+) T cells infiltrated into the tumor. These findings uncover additional molecular mechanisms of how CD4(+) T cell help regulates CD8(+) T cell differentiation during persistent infection and have implications toward optimizing the generation of protective CD8(+) T cells in immunotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available